DeepDyeDrop: an image-based approach to quantify the phenotypic response of cancer cells to therapeutics (Conference Presentation)

Marc Hafner; Caitlin E. Mills; Luca Gerosa; Mirra Chung; Mario Niepel; Peter K. Sorger

doi:10.1117/12.2293204

14 March 2018 DeepDyeDrop: an image-based approach to quantify the phenotypic response of cancer cells to therapeutics (Conference Presentation)

Marc Hafner, Caitlin E. Mills, Luca Gerosa, Mirra Chung, Mario Niepel, Peter K. Sorger

Author Affiliations +

Proceedings Volume 10475, Visualizing and Quantifying Drug Distribution in Tissue II; 104750E (2018) https://doi.org/10.1117/12.2293204
Event: SPIE BiOS, 2018, San Francisco, California, United States

Abstract

Accurate measurement of the response of cancer cells to therapeutic agents is confounded by many variables. Lysate-based assays such as CellTiter-Glo® (CTG) are commonly used but rely on a surrogate of cell number (ATP in the case of CTG) and provide limited information on the phenotypic response to treatment. To characterize drug response at a single-cell level, we developed the DeepDyeDrop assay, a high throughput minimally disruptive microscopy-based assay. In brief, the assay involves plating cells in 384-well plates, delivering treatments of interest, and staining and fixing the treated plates at an appropriate time point. Nuclei are stained with Hoechst, dead cells with a membrane impermeable LIVE/DEAD (LDR) dye, cells progressing through S phase of the cell cycle with EdU, and cells in mitosis with a conjugated phospho-histone H3 (pH3) antibody. Images are acquired with a Perkin Elmer Operetta microscope, nuclei are segmented based on the Hoechst signal, and the intensity of all signals within the nuclear area are measured. After segmentation, we first identify dead cells based on the Hoechst and LDR signals. The remaining live cells are then assigned to the phases of the cell cycle based on their DNA content, and EdU and pH3 intensities. To quantify the differences among treatments, we relied on normalized growth rate inhibition (GR) metrics, which allow for the comparison of cell lines with variable division rates. We added new theoretical framework to the standard GR metrics to account for differential responses within a treated population of cells to independently score the contributions of the cytostatic and cytotoxic components to the overall response. By conducting the assay on a panel of breast cancer cell lines treated with a library of kinase inhibitors, we observed a wide range of responses that reflect drug mechanisms of action.

Conference Presentation

Citation Download Citation

Marc Hafner, Caitlin E. Mills, Luca Gerosa, Mirra Chung, Mario Niepel, and Peter K. Sorger "DeepDyeDrop: an image-based approach to quantify the phenotypic response of cancer cells to therapeutics (Conference Presentation)", Proc. SPIE 10475, Visualizing and Quantifying Drug Distribution in Tissue II, 104750E (14 March 2018); https://doi.org/10.1117/12.2293204

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available